VER 155008: Adenosine-Derived HSP 70 Inhibitor for Cancer and Chaperone Pathway Research

Executive Summary: VER 155008 is a small molecule inhibitor of the heat shock protein 70 (Hsp70) family with an IC₅₀ of 0.5 μM against Hsp70 ATPase activity (APExBIO product page). It disrupts anti-apoptotic functions of Hsp70, leading to apoptosis and reduced proliferation in colon and breast cancer cell lines (Agnihotri et al., 2025). VER 155008 also promotes degradation of Hsp90 client proteins, illustrating pathway crosstalk. The compound is highly soluble in DMSO (≥27.8 mg/mL), but insoluble in water. It is widely used in apoptosis assays and mechanistic studies of the Hsp70 chaperone pathway in cancer biology and stress signaling (Related Article).

Biological Rationale

Heat shock proteins (HSPs) are molecular chaperones essential for protein folding, stabilization, and cellular stress responses. The Hsp70 family—comprising Hsp70 (HSPA1A), Hsc70 (HSPA8), and Grp78 (HSPA5)—prevents protein aggregation and assists in refolding misfolded proteins, especially under conditions such as heat, oxidative, or proteotoxic stress (Agnihotri et al., 2025). Dysregulation of Hsp70 is linked to oncogenesis. Hsp70 overexpression is common in cancers, supporting tumor cell survival by inhibiting apoptosis and stabilizing oncoproteins. In neurodegenerative disease models, Hsp70 modulates protein phase separation and aggregation. Targeting Hsp70 with small molecule inhibitors like VER 155008 enables precise dissection of its role in both cancer biology and stress granule biology (Contrast: This article extends mechanistic insights into LLPS disruption).

Mechanism of Action of VER 155008 (HSP 70 inhibitor, adenosine-derived)

VER 155008 is an adenosine-derived molecule that competitively binds to the ATPase pocket of Hsp70, inhibiting its intrinsic ATPase activity (IC₅₀ = 0.5 μM under standard biochemical assay conditions, 37°C, pH 7.4) (APExBIO). This inhibition blocks the chaperone cycle, preventing Hsp70 from facilitating ATP-dependent substrate folding and protein stabilization. Consequently, client proteins—including those involved in cell cycle progression and apoptosis suppression—are destabilized and targeted for degradation. In cancer cells, this results in loss of anti-apoptotic signaling, induction of apoptosis, and a decrease in cell proliferation. Additionally, VER 155008 indirectly accelerates degradation of Hsp90 client proteins, revealing functional crosstalk between chaperone networks. In models of stress-induced nuclear condensation, Hsp70 activity maintains the fluidity of TDP-43 nuclear condensates; inhibition by VER 155008 disrupts this maintenance, leading to pathological protein aggregation (Agnihotri et al., 2025).

Evidence & Benchmarks

• VER 155008 inhibits Hsp70 ATPase activity with an IC₅₀ of 0.5 μM in purified protein assays (APExBIO, product page).
• In human breast (BT474, MB-468) and colon cancer (HCT116, HT29) cell lines, VER 155008 induces apoptosis and inhibits cell proliferation with GI₅₀ values of 5.3–14.4 μM (APExBIO, product page).
• VER 155008 promotes degradation of Hsp90 client proteins in cancer cells (APExBIO, product page).
• Hsp70 inhibition by small molecules disrupts the maintenance of TDP-43 nuclear condensate fluidity in cellular stress models (Agnihotri et al., 2025).
• VER 155008 is insoluble in water but soluble in DMSO at ≥27.8 mg/mL; moderate ethanol solubility requires gentle warming and ultrasonic treatment (APExBIO, product page).
• The compound is stable as a solid at –20°C, but solutions are not suitable for long-term storage (APExBIO, product page).
• Hsp70 colocalizes with TDP-43 nuclear condensates to maintain their fluidity; its delocalization via inhibition leads to TDP-43 oligomerization and toxicity (Figure 1, Agnihotri et al., 2025).

Applications, Limits & Misconceptions

VER 155008 is primarily used for:

• Mechanistic studies of Hsp70 function in cancer cell survival and apoptosis (This article further details protein phase separation implications).
• Dissecting heat shock protein signaling, especially crosstalk with Hsp90 pathways.
• Modeling stress-induced nuclear condensation and protein aggregation in neurodegenerative disease research.
• Designing apoptosis assays and evaluating small molecule chaperone inhibitors (Compared to this, the current article provides updated benchmarks and workflow integration).

Common Pitfalls or Misconceptions

• VER 155008 is not cell-type agnostic; efficacy varies depending on Hsp70 expression levels.
• It does not inhibit Hsp90 directly, though it may affect Hsp90 client protein stability via network effects.
• Water insolubility precludes direct aqueous dosing; DMSO is the recommended solvent for stock solutions.
• Long-term storage of VER 155008 solutions leads to degradation; use freshly prepared solutions.
• VER 155008 is a research-use only compound; it is not for therapeutic or diagnostic purposes.

Workflow Integration & Parameters

Researchers should dissolve VER 155008 in DMSO at concentrations up to 27.8 mg/mL for stock solutions. For cell-based assays, dilute stocks into culture medium to achieve desired working concentrations, typically 5–15 μM for cancer cell lines (e.g., BT474, HCT116). Avoid prolonged storage of solutions; prepare aliquots and store the solid at –20°C. For biochemical ATPase inhibition assays, use purified Hsp70 proteins with ATP at physiological pH and temperature (7.4; 37°C). For apoptosis or proliferation assays, incubate cells with VER 155008 for 24–72 hours and assess via TUNEL, annexin V, or MTT protocols. For nuclear condensate studies, treat cells under stress conditions and monitor protein aggregation via microscopy, referencing protocols in Agnihotri et al., 2025 (DOI).

Conclusion & Outlook

VER 155008 is a rigorously benchmarked, potent Hsp70 inhibitor developed by APExBIO for research applications in cancer and protein homeostasis. Its precise inhibition of Hsp70 ATPase activity enables studies of apoptosis, stress granule biology, and chaperone-mediated signaling. Recent findings on phase separation and nuclear condensate biology expand its utility beyond oncology. For full product specifications and ordering, see the VER 155008 (HSP 70 inhibitor, adenosine-derived) product page. For extended mechanistic discussion and troubleshooting, consult this workflow-focused article, which this summary complements with new evidence and recommendations.